Halyard Health, Inc. (HYH) EPS Estimated At $-0.04

April 17, 2018 - By Margaret Downey

Halyard Health, Inc. (NYSE:HYH) Logo

Analysts expect Halyard Health, Inc. (NYSE:HYH) to report $-0.04 EPS on May, 1.They anticipate $0.52 EPS change or 108.33 % from last quarter’s $0.48 EPS. After having $0.73 EPS previously, Halyard Health, Inc.’s analysts see -105.48 % EPS growth. The stock increased 1.63% or $0.77 during the last trading session, reaching $47.87. About 244,163 shares traded. Halyard Health, Inc. (NYSE:HYH) has risen 20.55% since April 17, 2017 and is uptrending. It has outperformed by 9.00% the S&P500.

Halyard Health, Inc. operates as a medical technology firm that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. The company has market cap of $2.25 billion. The firm operates through two divisions, Medical Devices and Surgical and Infection Prevention . It has a 28.33 P/E ratio. The Medical Devices segment provides a portfolio of products that focuses on pain management, and respiratory and digestive health to enhance patient outcomes.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.